Hilltop Biosciences Inc. — Form D/A

Hilltop Biosciences Inc. of Norwood, MA, a company, filed a Form D amendment with the SEC on 2023-02-17. The offering totals $1.0M, of which $370K was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-02-17
Form: D/A
Accession: 0001782084-23-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.0M
Amount sold: $370K
Remaining: $630K
Investors: 35
Date of first sale: 2022-12-20
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-469527

Issuer

Name: Hilltop Biosciences Inc.
CIK: 0001782084
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 320 Norwood Park, S, Norwood, MA, 02062
Phone: 617-237-0636

Officers, directors & promoters (9)

Name	Role	Location
Mark Williams	Director	SAN JUAN, PR
Mark Williams	Executive Officer	SAN JUAN, PR
Jessica McLear	Director	Norwood, MA
Alan Watson	Director	Norwood, MA
Denise Bevers	Director	Norwood, MA
Amanda Drobnis	Director	Norwood, MA
Amanda Drobnis	Executive Officer	Norwood, MA
Denise Beavers	Director	Mansfield, MA
Jill Wittels	Director	Norton, MA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2025-03-31	D/A	$5.5M	$5.3M
2024-12-12	D	$5.5M	$4.3M
2023-04-03	D/A	$1.0M	$724K
2023-01-03	D	$1.0M	$295K
2021-10-04	D/A	$1.4M	$866K
2021-08-27	D	$1.4M	$784K
2020-05-29	D	$450K	$150K
2019-07-11	D	$1.0M	$751K

More